Marsh & McLennan Companies (NYSE:MRSH) Price Target Lowered to $203.00 at UBS Group

Marsh & McLennan Companies (NYSE:MRSH) had its price target reduced by equities research analysts at UBS Group from $230.00 to $203.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. UBS Group’s target price would suggest a potential upside of 22.63% from the stock’s current price.

A number of other equities research analysts have also recently weighed in on MRSH. Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Piper Sandler reduced their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Raymond James Financial raised Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective on the stock in a research note on Tuesday, February 17th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a research note on Wednesday, May 6th. Finally, Morgan Stanley cut their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research note on Monday, April 6th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $200.19.

Marsh & McLennan Companies Price Performance

Shares of Marsh & McLennan Companies stock traded up $3.02 during trading on Tuesday, hitting $165.54. 435,716 shares of the company were exchanged, compared to its average volume of 3,017,447. The firm has a market capitalization of $79.97 billion, a P/E ratio of 20.65, a PEG ratio of 2.41 and a beta of 0.62. Marsh & McLennan Companies has a 1-year low of $156.60 and a 1-year high of $222.57. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. The company’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts anticipate that Marsh & McLennan Companies will post 10.38 EPS for the current year.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Solstein Capital LLC bought a new position in Marsh & McLennan Companies in the 4th quarter worth about $25,000. Asset Dedication LLC bought a new position in shares of Marsh & McLennan Companies during the 1st quarter valued at about $25,000. SHP Wealth Management bought a new position in shares of Marsh & McLennan Companies during the 4th quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp bought a new position in Marsh & McLennan Companies during the 4th quarter worth approximately $27,000. Finally, Golden State Wealth Management LLC bought a new position in Marsh & McLennan Companies during the 4th quarter worth approximately $27,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.